De novo missense variants disrupting protein-protein interactions affect risk for autism through gene co-expression and protein networks in neuronal cell types.
Molecular Mechanisms
Inflammation of the embryonic choroid plexus barrier following maternal immune activation.
Regulation of neural gene expression by estrogen receptor alpha.
Human cerebral organoids reveal early spatiotemporal dynamics and pharmacological responses of UBE3A.
Chd8 haploinsufficiency impairs early brain development and protein homeostasis later in life.

How do neurexins promote presynaptic development?
Neurexins constitute a family of presynaptic transmembrane molecules that are encoded by three distinct genes, and mutations in all three genes are associated with risk for autism spectrum. In mammals, neurexins are expressed as thousands of different splice isoforms, all containing an invariant intracellular domain responsible for an as yet uncharacterized downstream signaling pathway. In the current project, Peri Kurshan and colleagues plan to use the simpler in vivo system afforded by the nematode C. elegans, along with a recently developed proteomics approach, to identify the proteins responsible for neurexin’s downstream signaling pathway(s).
FMRP sustains presynaptic function via control of activity-dependent bulk endocytosis.
Autism BrainNet.
Integrative genomics identifies a convergent molecular subtype that links epigenomic with transcriptomic differences in autism.
Loss of NARS1 impairs progenitor proliferation in cortical brain organoids and leads to microcephaly.
- Previous Page
- Viewing
- Next Page